Status:
UNKNOWN
General Practitioners and Participation Rate in ColoRectal Cancer Screening
Lead Sponsor:
University Hospital, Brest
Conditions:
Colorectal Cancer
Eligibility:
All Genders
50-74 years
Phase:
NA
Brief Summary
Colorectal cancer is the 2nd leading cause of cancer mortality in France. However this cancer is preventable in the majority of cases by early detection of adenomas. In France, there is organized col...
Eligibility Criteria
Inclusion
- People with an average risk of colorectal cancer (presenting no symptoms or risk factors).
- People living in Finistère.
- People aged 50 to 74 who have never participated in organized screening for colorectal cancer.
Exclusion
- Persons without address to receive the Health Belief Model (HBM)questionnaire
- People who do not fit the organized screening criteria
- Persons unable to give consent (patients under guardianship, curatorship, non-French speaking, illiterate)
Key Trial Info
Start Date :
May 31 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 31 2025
Estimated Enrollment :
902 Patients enrolled
Trial Details
Trial ID
NCT04492215
Start Date
May 31 2021
End Date
May 31 2025
Last Update
April 7 2023
Active Locations (53)
Enter a location and click search to find clinical trials sorted by distance.
1
Dr ABALAIN
Brest, France, 29200
2
Dr HENRY
Brest, France, 29200
3
Dr PETTON-HILI
Brest, France, 29200
4
Dr DENIEL
Châteauneuf-du-Faou, France, 29520